返回 Agenda
LS11 Model-Informed Drug Development: Application of MIDD to the Development of Novel Drugs for Treatment of COVID-19 Has Changed the World
Session Chair(s)
So Miyoshi
Head of Clinical Pharmacology & Bioanalytics
Pfizer R&D Japan, Japan
Speaker(s)
Akiyuki Suzuki, MS
Pfizer Japan Inc., Japan
Senior Manager, Pharmacometrics Group, Clinical Pharmacology
Tsuyoshi Shiga
Tokyo Women's Medical University, Japan
Associate Professor, Department of Cardiology
Daisuke Iwata
Pharmaceuticals and Medical Devices Agency, Japan
Office of Advanced Evaluation with Electronic Data